Bell & Brown Wealth Advisors, LLC Immunity Bio, Inc. Transaction History
Bell & Brown Wealth Advisors, LLC
- $278 Million
- Q2 2025
A detailed history of Bell & Brown Wealth Advisors, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Bell & Brown Wealth Advisors, LLC holds 77,750 shares of IBRX stock, worth $189,710. This represents 0.07% of its overall portfolio holdings.
Number of Shares
77,750
Previous 58,700
32.45%
Holding current value
$189,710
Previous $176,000
16.48%
% of portfolio
0.07%
Previous 0.07%
Shares
8 transactions
Others Institutions Holding IBRX
# of Institutions
259Shares Held
82.5MCall Options Held
1.09MPut Options Held
2.73M-
Vanguard Group Inc Valley Forge, PA21.8MShares$53.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$27.9 Million0.0% of portfolio
-
State Street Corp Boston, MA7.58MShares$18.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA5.78MShares$14.1 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.45MShares$8.41 Million0.07% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $977M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...